Inflammatory bowel disease and translational gastroenterology

Our research aims to improve the quality of life of patients with inflammatory bowel disease (IBD, including microscopic colitis, and also of patients with other gastrointestinal diseases. Exploring the molecular profile of these diseases is an integral part of projects performed in our research group.

The overarching aim of our research is to identify markers for improved clinical decision making and to uncover pathophysiological mechanisms behind these markers or signatures of markers. Epidemiological and mechanistic links between various disease elements and across different phases of the diseases are examined. Our research programs are conducted in collaboration with national and international research groups, patient organisations, and private companies within the biomarker-, pharmaceutical- and digital sector.

We research how various interventions can improve metabolic health. Using different techniques, we study how important organs such as the brain, liver, and gut are affected by obesity and weight loss.

Research Goals We have facilities to study human metabolism, which allows us to conduct translational research aimed at understanding the development of obesity and metabolic diseases such as metabolic dysfunction-associated fatty liver disease (MAFLD). We examine physiological parameters, develop intervention programs, and implement them in a way that they can be maintained over time. Examples include prevention and treatment programs through the endoscopy unit, obesity unit, and online.